Advanced 2D-LC/MS Workflow for Semaglutide Characterization

This application note presents a technical report detailing a workflow for the characterization and impurity analysis of the GLP-1 receptor agonist peptide semaglutide. The methodology integrates the Agilent 1290 Infinity III bio 2D-LC system with an Agilent 6545XT AdvanceBio LC/Q-TOF and MassHunter BioConfirm software, version 12.1. The workflow aims to identify and characterize peptide-related impurities in semaglutide, which is essential due to the challenges posed by impurities during the GMP manufacturing phase. The report outlines the use of a two-dimensional liquid chromatography (2D-LC) strategy, where the first dimension achieves high chromatographic resolution with a phosphate buffer-based separation, while the second dimension facilitates mass spectrometry detection. The application note emphasizes the importance of impurity management in maintaining product integrity and provides detailed experimental parameters, instrumentation specifications, and data acquisition methods utilized in the analysis. This approach enhances sensitivity and provides a more comprehensive characterization of impurities compared to conventional methods.